,88 Finally, sEH inhibition does not modify insulin sensitivity in patients with obesity and prediabetes89 and loss of EPHX1 activity causes lipoatrophic diabetes syndrome.90 Here, EPHX2 is linked to obesity due to melanocortin 4 receptor deficiency.